Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial infarction risk and hormone replacement: differences between products.

C S de Vries1, S E Bromley, R D T Farmer

  • 1Department of Pharmacoepidemiology, Postgraduate Medical School, University of Surrey, Daphne Jackson Road, Manor Farm Park, Guildford, Surrey, GU2 7WG, UK. c.de-vries@surrey.ac.uk

Maturitas
|July 26, 2005
PubMed
Summary

Hormone replacement therapy (HRT) use is linked to a lower risk of myocardial infarction (MI) and reduced fatality from MI. Different HRT regimens did not show varying risk levels for heart attack.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HRT and breast cancer: a million women ride again.

Climacteric : the journal of the International Menopause Society·2020
Same author

Medicine safety in pregnancy and ambitions for the EU medicine regulatory framework.

Clinical pharmacology and therapeutics·2016
Same author

Pregnancy losses in women with Type 1 or Type 2 diabetes in the UK: an investigation using primary care records.

Diabetic medicine : a journal of the British Diabetic Association·2013
Same author

Feasibility, reliability, and sensitivity to change of four radiographic scoring methods in patients with psoriatic arthritis.

Arthritis care & research·2013
Same author

Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!

The International journal of risk & safety in medicine·2013
Same author

Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women.

Acta gastro-enterologica Belgica·2013

Area of Science:

  • Cardiovascular Health
  • Endocrinology
  • Pharmacology

Background:

  • Hormone replacement therapy (HRT) is widely used for menopausal symptoms.
  • The association between HRT and cardiovascular events, particularly myocardial infarction (MI), remains a significant area of research.
  • Understanding the comparative risks across different HRT regimens is crucial for clinical practice.

Purpose of the Study:

  • To determine the risk of myocardial infarction (MI) in hormone replacement therapy (HRT) users versus non-users.
  • To compare the risk of MI among various HRT regimens, modes of administration, and durations of use.

Main Methods:

  • A population-based cohort and case-control study design was employed.
  • Data were sourced from the UK General Practice Research Database.

Related Experiment Videos

  • Confounding factors were adjusted for, and analyses examined differences in HRT regimen, administration, and duration.

    • Main Results:

    • Both current and past HRT use were associated with a reduced risk of MI compared to no prior use.
    • Myocardial infarctions were less likely to be fatal in HRT users (OR(adj) 0.58; 95% CI 0.45-0.75).
    • No significant differences in MI risk were observed between current and past use, oral versus transdermal HRT, or different HRT regimens.

    Conclusions:

    • Findings support the hypothesis that postmenopausal HRT use is associated with a decreased risk of acute myocardial infarction (AMI).
    • A protective effect of HRT is suggested by the difference in case fatality between users and non-users.
    • This study did not identify significant differences in MI risk among various HRT regimens.